Article Details

bluebird bio, Inc. (NASDAQ:BLUE) Expected to Post Quarterly Sales of $19.87 Million

Retrieved on: 2021-06-17 06:56:15

Tags for this article:

Click the tags to see associated articles and topics

bluebird bio, Inc. (NASDAQ:BLUE) Expected to Post Quarterly Sales of $19.87 Million. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 3,861,648 shares of the biotechnology company's stock valued at $167,093,000 after acquiring an additional 129,254 shares ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up